TOWER COLD CHAIN SETS SIGHTS ON DOUBLING ITS GLOBAL NETWORK AS L.A. HUB OPENS
With the launch of its Los Angeles hub, Tower Cold Chain confirms it is on track to double the size of its global network during 2022. Each new hub helps pharmaceutical businesses and airlines to access Tower’s range of robust, reliable and reusable temperature-controlled containers. The latest hub, located 18 miles from LAX International Airport, […]
SONOTEC LAUNCHES NEW GENERATION OF ITS HIGH ACCURACY CLAMP-ON FLOW METER SONOFLOW CO.55
Ultrasonic specialist SONOTEC enhanced its SONOFLOW® CO.55 non-contact flow meter to increase the efficiency throughout PAT-related upstream and downstream processes in biotechnology applications. The new SONOFLOW CO.55 V3.0 sensor combines outstanding measurement accuracy and the highest clamp-to-clamp repeatability. SONOFLOW CO.55 V3.0 is the world’s most accurate ultrasonic clamp-on sensor with a measurement accuracy of up […]
AENOVA ACHIEVES SILVER MEDAL IN ECOVADIS SUSTAINABILITY RATING
Aenova, the world’s leading contract development and manufacturer for the pharmaceutical and healthcare industries, has achieved silver status in the latest EcoVadis sustainability rating. This documents the Aenova Group’s continuous improvement of its sustainability in the categories “environment”, “labor and human rights”, “ethics” and “sustainable procurement”. Starnberg, May 10, 2022 – Certified proof of sustainability […]
SONOTEC WITH NEW FLOW SENSOR GENERATION AT INTERPHEX
SONOTEC presents its new non-contact flow meter SONOFLOW® CO.55 V3.0 at one of the major bioprocessing and pharma events in the USA. Besides outstanding measurement accuracy and the highest clamp-to-clamp repeatability, the ultrasonic sensor combines measurement excellence and state-of-the-art industry 4.0 features. With a measurement accuracy of up to 1% and hardly any drift at […]
SGS WINS FIVE CATEGORIES IN THE 2022 CRO LEADERSHIP AWARDS
SGS has again been rewarded for its industry-leading work, receiving five 2022 CRO Leadership Awards in the categories of Capabilities, Compatibility, Expertise, Quality and Reliability. This is the sixth consecutive year that SGS has been recognized. The CRO Leadership Awards, launched by the esteemed Life Sciences Leader and Clinical Leader journals, seek to reward outstanding CROs that […]
DIGITAL PRODUCT PROTECTION MEETS SUSTAINABLE SECURITY LABELS MADE FROM PAPER
Securikett’s sustainable product range now gets a digital extension Sustainable packaging and product digitization in one step Sustainable packaging is a hot topic and Securikett was a pioneer in presenting a secure and attractive solution to meet this requirement with its “IT’S PAPER” product series. Now the Austrian company is going one step further and […]
FDA SLAPS PARTIAL HOLD ON CURIS LEUKEMIA STUDY
Curis’ phase 1/2a leukaemia study is the latest to join the club of FDA clinical holds, following the death of a trial participant. The Massachusetts-based biotech announced the partial clinical hold today, citing the FDA’s request for additional safety and efficacy data, including more information about the patient death. The trial on pause is TakeAim Leukemia, which […]
NOVARTIS UNVEILS MAJOR RE-ORG
Novartis has announced a new organizational structure and operating model, with an eye on innovation and growth — as well as targeted savings of at least $1 billion by 2024. The Swiss giant’s new “simplified structure and operational set-up” will integrate the pharmaceuticals and oncology business units, creating two separate commercial organizations with a stronger geographic focus […]
PARSORTIX SYSTEM IDENTIFIES KEY DRUG TARGETS IN CANCER METASTASIS
The study demonstrates the ability of the Parsortix system to isolate circulating tumour cells, targeting the metastatic spread of cancer. Liquid biopsy company Angle has announced the results of work undertaken in preclinical models of metastatic breast cancer (MBC), where specific genes involved in the metastatic process have been identified. The study adds to the […]
POSITIVE RESULTS FOR CEREVANCE’S PARKINSON’S DRUG
In phase 2 trials, the drug reduced ‘OFF time’ which refers to periods of the day when Parkinson’s symptoms recur despite medication Cerevance has announced positive phase 2 trial results for the company’s first-in-class, once-a-day, orally-administered compound treating Parkinson’s disease. The company is a private, clinical-stage drug discovery and development company focused on central nervous […]